Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Potassium Channel
    (3)
  • ATPase
    (1)
  • Others
    (1)
TargetMol | Tags By ResearchField
  • Metabolism
    (3)
Filter
Search Result
Results for "

kad 1229

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    3
    TargetMol | All_Pathways
  • Mitiglinide calcium hydrate
    S-21403 calcium hydrate, KAD-1229 calcium hydrate
    T1530207844-01-7
    Mitiglinide calcium hydrate (S-21403 calcium hydrate) is a drug for the treatment of type 2 diabetes. Mitiglinide is thought to stimulate insulin secretion by closing the ATP-sensitive K(+) K(ATP) channels in pancreatic beta-cells. Mitiglinide belongs to the meglitinide class of blood glucose-lowering drugs and is currently co-marketed in Japan by Kissei and Takeda.
    • $73
    In Stock
    Size
    QTY
  • Mitiglinide Calcium
    S21403, KAD-1229
    T6587145525-41-3
    Mitiglinide Calcium (KAD-1229) is a blood glucose-lowering drugs, stimulating insulin secretion by closing the ATP-sensitive K+ channels in pancreatic beta-cells.
    • $40
    In Stock
    Size
    QTY
  • Mitiglinide
    T21431145375-43-5
    Mitiglinide (KAD-1229) is an insulinotropic agent that is an ATP-sensitive K + (K ATP ) channel antagonist. Mitiglinide is highly specific to the Kir6.2/SUR1 complex (the pancreatic beta-cell K ATP channel). Mitiglinide is able to be used for the research of type 2 diabetes [1] [2].
    • $1,520
    1-2 weeks
    Size
    QTY